Freely Available Online www.openaccesspub.org | JAPST CC-license DOI : 10.14302/issn.2328-0182.japst- 17-1714 Vol-1 Issue - 3 Page No- 29 JOURNAL OF ADVANCED PHARMACEUTICAL SCIENCE AND TECHNOLOGY ISSN NO: 2328-0182 Research Artcle A New Spectrofluorimetric Approach for the Quantitation of Imipramine Hcl in Commercial Dosage Forms Abstract A spectrofluorimetric method has been developed for the determination of imipramine HCl in bulk and commercial dosage forms. The method was based on measuring the fluorescence emission intensity of imipramine -eosin Y ion pair complex (λ em = 558 and λ ex = 319) in dichloroethane at buffer solution (sodium acetate and acetic acid) of pH 4.8. The stoichiometric ratio between imipramine and eosin Y was studied by Job's method of continuous variations and found to be 2:1. Formation constant (K f ) and Gibb’s free energy change (ΔG) were calculated and pointed towards the spontaneous nature of the reaction. A series of variables were studied to optimize the reaction conditions. The proposed method was validated as per ICH guidelines and successfully applied for the determination of active imipramine HCl in commercial dosage forms with high degree of accuracy and precision. Syed Najmul Hejaz Azmi 1 *, Manal Khalifa Al -Hattali 1 , Ruiyah Khalifa Al-Hinai 1 , Ibtihal Mohammed Al-Ajmi 1 1. Department of Applied Sciences, Chemistry Section, Higher College of Technology, P. O. Box 74, Al -Khuwair- 133, Muscat, Sultanate of Oman Corresponding author: Syed Najmul Hejaz Azmi, Email id: snhazmi@yahoo.com Keywords: : imipramine HCl; spectrofluorimetry, validation; ICH guideline, commercial dosage forms Received Jul 20,2017; Accepted Sep 02,2017; Published : Sep 04 ,2017 DOI : 10.14302/issn.2328-0182.japst-17-1714